Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in cardiovascular disease

被引:24
|
作者
Lezutekong, Judith N. [1 ]
Nikhanj, Anish [2 ,3 ]
Oudit, Gavin Y. [2 ,3 ]
机构
[1] Univ Alberta, Dept Physiol, Edmonton, AB, Canada
[2] Univ Alberta, Div Cardiol, Dept Med, Edmonton, AB, Canada
[3] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada
基金
加拿大健康研究院;
关键词
HEART-FAILURE; DIET; HYPERTENSION;
D O I
10.1042/CS20180172
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The main function of the intestinal barrier is to regulate the absorption of nutrients, electrolytes, and water from the lumen into circulation and to prevent the entry of pathogenic microorganisms and toxic luminal substances. To maintain this function, an ideal microbiota balance is required and gut microbiota are critical for the intestinal epithelial barrier dysfunction and for the maintenance of physiological homeostasis. There is a demonstrable link between dysbiosis and intestinal dysfunction and diseases such as diabetes, obesity, and cardiovascular disease. However, links amongst gut pathology, microbial ecology, and blood pressure remain elusive. In a recent issue of Clinical Science (vol. 132, issue 6, 701-718), Kim et al. demonstrate a crucial link between gut microbiota and bacterial metabolites such as butyrate, gut leakiness, and hypertension.
引用
收藏
页码:901 / 904
页数:4
相关论文
共 50 条
  • [1] Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure
    Kim, Seungbum
    Goel, Ruby
    Kumar, Ashok
    Qi, Yanfei
    Lobaton, Gil
    Hosaka, Koji
    Mohammed, Mohammed
    Handberg, Eileen M.
    Richards, Elaine M.
    Pepine, Carl J.
    Raizada, Mohan K.
    [J]. CLINICAL SCIENCE, 2018, 132 (06) : 701 - 718
  • [2] Intestinal epithelial barrier dysfunction in Crohn's disease
    Ma, TY
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1997, 214 (04): : 318 - 327
  • [3] Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease
    Lewis, Caitlin, V
    Taylor, W. Robert
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2020, 319 (06): : H1227 - H1233
  • [4] Regulation of gut epithelial barrier by microbiome metabolites
    Pat, Y.
    Yazici, D.
    Ogulur, I.
    Ardicli, S.
    Simmons, S.
    Almada, A.
    Avena, C.
    Jensen, T.
    Li, M.
    Mitamura, Y.
    Babayev, H.
    Heider, A.
    Dhir, R.
    Akdis, M.
    Nadeau, K.
    Akdis, C.
    [J]. SWISS MEDICAL WEEKLY, 2023, 153 : 18S - 19S
  • [5] The Gut Microbiome and Cardiovascular Disease
    Astudillo, Andrea A.
    Mayrovitz, Harvey N.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [6] Gut microbiome and cardiovascular disease
    Zhao, Yongzhong
    Wang, Zeneng
    [J]. CURRENT OPINION IN CARDIOLOGY, 2020, 35 (03) : 207 - 218
  • [7] Intestinal Epithelial Barrier Dysfunction in Disease and Possible Therapeutical Interventions
    Catalioto, R. -M.
    Maggi, C. A.
    Giuliani, S.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2011, 18 (03) : 398 - 426
  • [8] Systemic imbalance in hormone levels associates with epithelial barrier dysfunction in allergic disease
    Berdnikovs, Sergejs
    Abdala-Valencia, Hiam
    Loffredo, Lucas F.
    Erickson, Kristin
    Browning, Mandy
    Saber, Rana
    Schleimer, Robert P.
    Singh, Anne Marie
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB263 - AB263
  • [9] Intestinal Microbiome and cardiovascular Disease
    Steffen, Hans-Michael
    Demir, Muenevver
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (14) : 957 - 963
  • [10] Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
    Chopyk, Daniel M.
    Grakoui, Arash
    [J]. GASTROENTEROLOGY, 2020, 159 (03) : 849 - 863